Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl
Matthias
M
Children's Hospital, Department of Pediatric Hematology and Oncology, University of Cologne, Cologne, Germany. mwolfl@fhcrc.org
Jungbluth
Achim A
AA
Garrido
Federico
F
Cabrera
Teresa
T
Meyen-Southard
Sharon
S
Spitz
Rüdiger
R
Ernestus
Karen
K
Berthold
Frank
F
D000951:Antigens, Neoplasm / Q000235:genetics / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D058950:Melanoma-Specific Antigens; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D009363:Neoplasm Proteins / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D009447:Neuroblastoma / Q000175:diagnosis / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013737:Testis / Q000378:metabolism
D000951:Antigens, Neoplasm; C104948:CTAG1B protein, human; C072011:MAGEA1 protein, human; C072013:MAGEA3 protein, human; C095203:MAGEA6 protein, human; D058950:Melanoma-Specific Antigens; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger